Yifeng Pharmacy Chain Co., Ltd. (603939.SS)
CNY 25.67
(-0.62%)
CNY 25.67
(-0.62%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 6.48 Billion CNY | 1090.76% |
| 2022 | -654.97 Million CNY | -261.82% |
| 2021 | 404.75 Million CNY | 142.85% |
| 2020 | -944.51 Million CNY | -45.5% |
| 2019 | -649.13 Million CNY | -27.8% |
| 2018 | -507.93 Million CNY | -482.81% |
| 2017 | 132.68 Million CNY | -66.7% |
| 2016 | 398.4 Million CNY | 774.65% |
| 2015 | 45.55 Million CNY | 115.75% |
| 2014 | -289.19 Million CNY | -30.63% |
| 2013 | -221.38 Million CNY | -38.13% |
| 2012 | -160.27 Million CNY | 17.15% |
| 2011 | -193.44 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 4.8 Billion CNY | -89.72% |
| 2024 Q1 | 5.75 Billion CNY | -11.39% |
| 2024 Q2 | 7.25 Billion CNY | 26.17% |
| 2023 Q3 | 84.08 Million CNY | -83.67% |
| 2023 Q4 | 6.48 Billion CNY | 7617.43% |
| 2023 FY | 6.48 Billion CNY | 1090.76% |
| 2023 Q1 | -85.08 Million CNY | 87.01% |
| 2023 Q2 | 514.85 Million CNY | 705.12% |
| 2022 Q4 | -654.97 Million CNY | -238.88% |
| 2022 Q3 | 471.62 Million CNY | -63.21% |
| 2022 Q1 | 848.51 Million CNY | 109.64% |
| 2022 Q2 | 1.28 Billion CNY | 51.07% |
| 2022 FY | -654.97 Million CNY | -261.82% |
| 2021 Q1 | 587.14 Million CNY | 162.16% |
| 2021 Q4 | 404.75 Million CNY | -63.11% |
| 2021 Q3 | 1.09 Billion CNY | -9.6% |
| 2021 FY | 404.75 Million CNY | 142.85% |
| 2021 Q2 | 1.21 Billion CNY | 106.7% |
| 2020 Q1 | -807.54 Million CNY | -24.4% |
| 2020 FY | -944.51 Million CNY | -45.5% |
| 2020 Q3 | -550.56 Million CNY | -557.76% |
| 2020 Q4 | -944.51 Million CNY | -71.55% |
| 2020 Q2 | 120.27 Million CNY | 114.89% |
| 2019 FY | -649.13 Million CNY | -27.8% |
| 2019 Q4 | -649.13 Million CNY | -16.55% |
| 2019 Q3 | -556.94 Million CNY | -49.41% |
| 2019 Q2 | -372.75 Million CNY | 6.71% |
| 2019 Q1 | -399.58 Million CNY | 21.33% |
| 2018 Q2 | -795.06 Million CNY | 8.71% |
| 2018 Q4 | -507.93 Million CNY | -21.12% |
| 2018 Q3 | -419.37 Million CNY | 47.25% |
| 2018 Q1 | -870.88 Million CNY | -10.58% |
| 2018 FY | -507.93 Million CNY | -482.81% |
| 2017 Q1 | -399 Million CNY | -15.11% |
| 2017 FY | 132.68 Million CNY | -66.7% |
| 2017 Q4 | -787.53 Million CNY | -91.07% |
| 2017 Q3 | -412.16 Million CNY | -7.3% |
| 2017 Q2 | -384.12 Million CNY | 3.73% |
| 2016 Q3 | -829.37 Million CNY | -117.37% |
| 2016 Q2 | -381.55 Million CNY | 7.04% |
| 2016 Q1 | -410.44 Million CNY | 26.65% |
| 2016 FY | 398.4 Million CNY | 774.65% |
| 2016 Q4 | -346.63 Million CNY | 58.21% |
| 2015 Q1 | -799.91 Million CNY | -176.6% |
| 2015 Q4 | -559.59 Million CNY | -67.48% |
| 2015 Q3 | -334.13 Million CNY | 26.37% |
| 2015 Q2 | -453.81 Million CNY | 43.27% |
| 2015 FY | 45.55 Million CNY | 115.75% |
| 2014 Q1 | 221.38 Million CNY | 0.0% |
| 2014 FY | -289.19 Million CNY | -30.63% |
| 2014 Q2 | -224.2 Million CNY | -201.28% |
| 2014 Q4 | -289.19 Million CNY | 0.0% |
| 2013 FY | -221.38 Million CNY | -38.13% |
| 2012 FY | -160.27 Million CNY | 17.15% |
| 2011 FY | -193.44 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Shanghai No.1 Pharmacy Co., Ltd. | -73.11 Million CNY | 8974.995% |
| Jointown Pharmaceutical Group Co., Ltd | 21.81 Billion CNY | 70.259% |
| LBX Pharmacy Chain Joint Stock Company | 7.88 Billion CNY | 17.725% |
| Yunnan Jianzhijia Health-Chain Co., Ltd. | 2.83 Billion CNY | -128.654% |